Staged percutaneous coronary intervention and minimally invasive valve surgery: Results of a hybrid approach to concomitant coronary and valvular disease

Results: There were no in-hospital deaths in the hybrid group, compared with 2 (3.8%) observed in the matched group (P1⁄4 .11). Death, renal failure, or stroke occurred in 1 (1.5%) in the hybrid group versus 15 (28.8%) in the conventional group (P 1⁄4 .001). The median number of days between PCI and surgery was 24 (interquartile range, 2.5-37). At surgery, 23 hybrid patients were receiving both aspirin and clopidogrel;, 18, clopidogrel alone; 4, aspirin alone; and 22 stopped the antiplatelet agents 5 days before the operation. Intensive care unit hours and total hospital length of stay, including PCI stay for the hybrid group, were less in the hybrid group (P1⁄4 .001 for both comparisons). In the hybrid group, average blood use was 1.6 " 1.6 U per patient versus 1.9 " 2.4 U per patient with conventional surgery (P1⁄4 .35. There were no reoperations for postoperative bleeding in the hybrid group compared with 2 (3.8%) in the conventional group (P 1⁄4 .43).